ConductScience.org, home

Paper16734736

Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma.

Shimada H and 13 others. Cancer Sci, 2006. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. Papers, record 16734736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16734736

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma.
PubMed
Journal
Cancer Sci
PubMed
Year
2006
PubMed
Publication types
Clinical Trial, Phase I, Clinical Trial, Phase III, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
1.51
iCite
Revised in PubMed
2024-06-09
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shimada HHideaki
2Matsubara HHisahiro
3Shiratori TTooru
4Shimizu TTakanori
5Miyazaki SShinichi
6Okazumi SShinichi
7Nabeya YYoshihiro
8Shuto KKiyohiko
9Hayashi HHideki
10Tanizawa TTooru
11Nakatani YYukio
12Nakasa HHiromitsu
13Kitada MMitsukazu
14Ochiai TTakenori

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Esophageal NeoplasmsMajor topic
Genes, p53Major topic
Genetic TherapyMajor topic
Adenoviridae
Aged
Aged, 80 and over
Antibodies, Viral
Drug Resistance, Neoplasm
Female
Genetic Vectors
Humans
Male
Middle Aged
RNA, Messenger
Radiation Tolerance
Reverse Transcriptase Polymerase Chain Reaction
Transgenes

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112572873p53 gene therapy for esophageal cancer.J Gastroenterol2002https://conductscience.org/library/papers/12572873PubMed
216336610Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.Dis Esophagus2005https://conductscience.org/library/papers/16336610PubMed
312805322Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.J Clin Oncol2003https://conductscience.org/library/papers/12805322PubMed
415297186A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer.Gynecol Oncol2004https://conductscience.org/library/papers/15297186PubMed
516142339Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells.Oncol Rep2005https://conductscience.org/library/papers/16142339PubMed
611870536Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma.Br J Cancer2002https://conductscience.org/library/papers/11870536PubMed
710414702The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability.Am J Surg1999https://conductscience.org/library/papers/10414702PubMed
88081915Endoscopic argon plasma coagulation (APC) first clinical experiences in flexible endoscopy.Endosc Surg Allied Technol1994https://conductscience.org/library/papers/8081915PubMed
912538456Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.Clin Cancer Res2003https://conductscience.org/library/papers/12538456PubMed
102263646Frequent mutation of the p53 gene in human esophageal cancer.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2263646PubMed
1112563234Treatment response and prognosis of patients after recurrence of esophageal cancer.Surgery2003https://conductscience.org/library/papers/12563234PubMed
129626224Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.J Clin Oncol1998https://conductscience.org/library/papers/9626224PubMed
1311023193P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.Cancer Gene Ther2000https://conductscience.org/library/papers/11023193PubMed
1411495154Preclinical study of adenoviral p53 gene therapy for esophageal cancer.Surg Today2001https://conductscience.org/library/papers/11495154PubMed
158782455Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.Nat Med1996https://conductscience.org/library/papers/8782455PubMed
167621238High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.Cancer Gene Ther1994https://conductscience.org/library/papers/7621238PubMed
1710328106Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.J Natl Cancer Inst1999https://conductscience.org/library/papers/10328106PubMed

Download CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
42766263Opportunities in cancer gene therapy: inhibiting MDM2 and restoring p14ARF as a means to activate p53.Mol Cell Biochem2026https://conductscience.org/library/papers/42766263PubMed
41884820The guardian of the genome meets immunotherapy: p53-based strategies.Front Immunol2026https://conductscience.org/library/papers/41884820PubMed
39961936Integrating alternative therapies in overcoming chemotherapy resistance in tumors.Mol Biol Rep2025https://conductscience.org/library/papers/39961936PubMed
39598704Advancements in p53-Based Anti-Tumor Gene Therapy Research.Molecules2024https://conductscience.org/library/papers/39598704PubMed
34769370Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?Int J Mol Sci2021https://conductscience.org/library/papers/34769370PubMed
34769259Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents.Int J Mol Sci2021https://conductscience.org/library/papers/34769259PubMed
33060772Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models.Sci Rep2020https://conductscience.org/library/papers/33060772PubMed
33009508The changing face of gastric cancer: epidemiologic trends and advances in novel therapies.Cancer Gene Ther2021https://conductscience.org/library/papers/33009508PubMed
31384232The Evolving Landscape of Gene Therapy in Plastic Surgery.Semin Plast Surg2019https://conductscience.org/library/papers/31384232PubMed
31346579Multidisciplinary oncolytic virotherapy for gastrointestinal cancer.Ann Gastroenterol Surg2019https://conductscience.org/library/papers/31346579PubMed
31015790Prostate Cancer Gene Regulatory Network Inferred from RNA-Seq Data.Curr Genomics2019https://conductscience.org/library/papers/31015790PubMed
30198865Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma.Cancer Biomark2018https://conductscience.org/library/papers/30198865PubMed
30170471Recombinant adenovirus-p53 enhances the therapeutic effect of surgery and chemoradiotherapy combination in hypopharyngeal squamous cell carcinomas patients.Medicine (Baltimore)2018https://conductscience.org/library/papers/30170471PubMed
30087719TP53 Mutation in Correlation to Immunohistochemical Expression of P53 Protein in Patients with Hepatocellular Carcinoma.Open Access Maced J Med Sci2018https://conductscience.org/library/papers/30087719PubMed
30003189p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma.Ann Gastroenterol Surg2018https://conductscience.org/library/papers/30003189PubMed
26900290Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.World J Gastroenterol2016https://conductscience.org/library/papers/26900290PubMed
26445307Targeting tumor suppressor genes for cancer therapy.Bioessays2015https://conductscience.org/library/papers/26445307PubMed
26241176Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.Gene Ther2016https://conductscience.org/library/papers/26241176PubMed
26059686Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression.BMC Cancer2015https://conductscience.org/library/papers/26059686PubMed
25732051Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo.Sci Rep2015https://conductscience.org/library/papers/25732051PubMed

See all 39 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
H3P16644914PubTator's text mininghttps://conductscience.org/library/genes/644914NCBI Gene
MDM24193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16734736

GET https://conductscience.org/api/papers/v1/16734736/cited_by?page=2